Schedule 13D ownership disclosure

MYMD PHARMACEUTICALS INC

Security class unavailable · CUSIP: 62856X102

Event date: 2024-05-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
11,563,878
Percent of class
83.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001683168-24-003883
Form type
SC 13D
Filer
Q/C TECHNOLOGIES, INC.
CIK
CIK 1321834
Filed
May 30, 2024
Reporting period
May 23, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub